Literature DB >> 24140988

Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior.

W Heydendael1, A Sengupta2, S Beck3, S Bhatnagar3.   

Abstract

Maladaptation to stress is associated with psychopathology. However, our understanding of the underlying neural circuitry involved in adaptations to stress is limited. Previous work from our lab indicated the paraventricular hypothalamic neuropeptides orexins/hypocretins regulate behavioral and neuroendocrine responses to stress. To further elucidate the role of orexins in adaptation to stress, we employed optogenetic techniques to specifically examine the effects of orexin cell activation on behavior in the social interaction test and in the home cage as well as orexin receptor 1 internalization and ERK phosphorylation in brain regions receiving orexin inputs. In the social interaction test, optogenetic stimulation of orexin neurons decreased time spent in the interaction zone while increasing the frequency of entries into the interaction zone. In addition, optogenetic stimulation of orexin neurons increased the total distance traveled in the social interaction arena but had no effect on their home cage behavior. Together, these results suggest that orexin release increases anxiety in the social interaction test while increasing the salience of novel but not familiar environmental stimuli. Consistent with activation of orexin neurons, optogenetic stimulation increased orexin receptor1 internalization and ERK phosphorylation in the paraventricular thalamus (PVT) and locus coeruleus (LC), two regions heavily innervated by orexin neurons. Together these results show for the first time that elevation of orexin activity, possibly in the PVT and LC, is associated with increased anxiety, activity, and arousal in a context-specific manner.
© 2013.

Entities:  

Keywords:  Anxiety; Hypocretins; Optogenetics; Orexins; Social interaction; Stress

Mesh:

Substances:

Year:  2013        PMID: 24140988      PMCID: PMC4155939          DOI: 10.1016/j.physbeh.2013.10.005

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  37 in total

1.  Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats.

Authors:  Yonghui Li; Sa Li; Chuguang Wei; Huiying Wang; Nan Sui; Gilbert J Kirouac
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

Review 2.  Physiological arousal: a role for hypothalamic systems.

Authors:  A Adamantidis; L de Lecea
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

3.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Differential expression of orexin receptors 1 and 2 in the rat brain.

Authors:  J N Marcus; C J Aschkenasi; C E Lee; R M Chemelli; C B Saper; M Yanagisawa; J K Elmquist
Journal:  J Comp Neurol       Date:  2001-06-18       Impact factor: 3.215

5.  Centrally administered orexin/hypocretin activates HPA axis in rats.

Authors:  M Kuru; Y Ueta; R Serino; M Nakazato; Y Yamamoto; I Shibuya; H Yamashita
Journal:  Neuroreport       Date:  2000-06-26       Impact factor: 1.837

6.  Orexins/hypocretins act in the posterior paraventricular thalamic nucleus during repeated stress to regulate facilitation to novel stress.

Authors:  Willem Heydendael; Kanika Sharma; Vikram Iyer; Sandra Luz; David Piel; Sheryl Beck; Seema Bhatnagar
Journal:  Endocrinology       Date:  2011-10-04       Impact factor: 4.736

7.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

9.  Orexins stimulate steroidogenic acute regulatory protein expression through multiple signaling pathways in human adrenal H295R cells.

Authors:  Manjunath Ramanjaneya; Alex C Conner; Jing Chen; Peter R Stanfield; Harpal S Randeva
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

10.  The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.

Authors:  S Zhang; L Lin; S Kaur; S Thankachan; C Blanco-Centurion; M Yanagisawa; E Mignot; P J Shiromani
Journal:  Neuroscience       Date:  2007-07-06       Impact factor: 3.590

View more
  29 in total

1.  Accumbal D2 cells orchestrate innate risk-avoidance according to orexin signals.

Authors:  Craig Blomeley; Celia Garau; Denis Burdakov
Journal:  Nat Neurosci       Date:  2017-11-27       Impact factor: 24.884

Review 2.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

3.  Activation of orexin/hypocretin neurons is associated with individual differences in cued fear extinction.

Authors:  Amanda C Sharko; Jim R Fadel; Kris F Kaigler; Marlene A Wilson
Journal:  Physiol Behav       Date:  2016-10-13

4.  High-resolution genetic mapping of complex traits from a combined analysis of F2 and advanced intercross mice.

Authors:  Clarissa C Parker; Peter Carbonetto; Greta Sokoloff; Yeonhee J Park; Mark Abney; Abraham A Palmer
Journal:  Genetics       Date:  2014-09       Impact factor: 4.562

5.  First-in-human study with ACT-539313, a novel selective orexin-1 receptor antagonist.

Authors:  Priska Kaufmann; Marion Ort; Georg Golor; Rüdiger Kornberger; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2020-03-06       Impact factor: 4.335

6.  Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms.

Authors:  L L Ferrari; L J Agostinelli; M J Krashes; B B Lowell; T E Scammell; E Arrigoni
Journal:  J Physiol       Date:  2016-01-05       Impact factor: 5.182

7.  CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety.

Authors:  Jordan G McCall; Ream Al-Hasani; Edward R Siuda; Daniel Y Hong; Aaron J Norris; Christopher P Ford; Michael R Bruchas
Journal:  Neuron       Date:  2015-07-23       Impact factor: 17.173

Review 8.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

9.  OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.

Authors:  Philip L Johnson; Lauren M Federici; Stephanie D Fitz; John J Renger; Brock Shireman; Christopher J Winrow; Pascal Bonaventure; Anantha Shekhar
Journal:  Depress Anxiety       Date:  2015-08-19       Impact factor: 6.505

10.  Involvement of orexin/hypocretin in the expression of social play behaviour in juvenile rats.

Authors:  Christina J Reppucci; Cassandra K Gergely; Remco Bredewold; Alexa H Veenema
Journal:  Int J Play       Date:  2020-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.